Unusual EMA and pan-keratin negative epithelioid sarcoma
Further research is needed to better understand the role of SMARCB1 loss in tumor immunogenicity to develop optimal immunotherapeutics and new treatment strategies for these aggressive tumors.
A. Alpeza, K. Gregorović, D. Alpeza and 4 others
Presented at 18. Nacionalni kongres Udruženja patologa i citologa Srbije sa međunarodnim učešćem, Novi Sad, 9–11 May 2024
